Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.90
Delayed Data
As of Apr 25
 0.00 / 0.00%
Today’s Change
0.85
Today|||52-Week Range
8.50
-71.73%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.90
Today’s open0.93
Day’s range0.90 - 0.96
Volume1,837,857
Average volume (3 months)1,503,631
Market cap$86.2M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-163.97%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio0.7
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATNMActinium Pharmaceuti...0.000.00%
VCELVericel Corp0.000.00%
SBPHSpring Bank Pharmace...-0.27-2.91%
NOVNNovan Inc+0.11+2.08%
Data as of 4:00pm ET, 04/25/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director &
Vice President
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs